# Allakos Inc. (ALLK)

Source: https://www.quantisnow.com/company/ALLK
Generated: 2026-11-11T10:26:41.113Z

- Ticker: ALLK
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: allakos.com

## About

Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California.

## Latest ALLK news and filings

- 2025-05-27 13:00 UTC [SEC Form 15-12G filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-allakos-inc-6058379)
- 2025-05-19 22:45 UTC [SEC Form 4] [Large owner Bvf Partners L P/Il returned 16,312,872 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-bvf-partners-l-pil-returned-16312872-shares-to-6048874)
- 2025-05-19 22:42 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-allakos-inc-6048863)
- 2025-05-19 20:15 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-allakos-inc-6047799)
- 2025-05-19 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-allakos-inc-6046650)
- 2025-05-19 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-allakos-inc-6046642)
- 2025-05-15 20:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043259)
- 2025-05-15 20:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043245)
- 2025-05-15 20:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043237)
- 2025-05-15 20:43 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043228)
- 2025-05-15 20:42 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043213)
- 2025-05-15 20:42 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043204)
- 2025-05-15 20:41 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043195)
- 2025-05-15 20:40 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-allakos-inc-6043182)
- 2025-05-15 20:38 UTC [SEC Form POS AM filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-allakos-inc-6043149)
- 2025-05-15 20:38 UTC [SEC Form POS AM filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-allakos-inc-6043138)
- 2025-05-15 20:28 UTC [SEC Form 4] [Director Walker Paul Edward returned 6,147,260 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/director-walker-paul-edward-returned-6147260-shares-to-the-company-6042871)
- 2025-05-15 20:08 UTC [SEC Form 4] [President Tomasi Adam returned 533,420 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-tomasi-adam-returned-533420-shares-to-the-company-closing-6042258)
- 2025-05-15 20:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Thomas Dolca](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-thomas-dolca-6042160)
- 2025-05-15 20:05 UTC [SEC Form 4] [Chief Financial Officer Radford Harlan Baird returned 163,426 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-radford-harlan-baird-returned-163426-shares-to-6042109)
- 2025-05-15 20:04 UTC [SEC Form 4] [SEC Form 4 filed by Director Ladd Amy L](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-ladd-amy-l-6041976)
- 2025-05-15 20:03 UTC [SEC Form 4] [SEC Form 4 filed by Director James Steven P](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-james-steven-p-6041963)
- 2025-05-15 20:02 UTC [SEC Form 4] [SEC Form 4 filed by Director Graham Neil Murray Hamilton](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-graham-neil-murray-hamilton-6041947)
- 2025-05-15 20:01 UTC [SEC Form 4] [SEC Form 4 filed by Director Andreatta Robert E](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-andreatta-robert-e-6041905)
- 2025-05-15 20:00 UTC [SEC Form 4] [Chief Executive Officer Alexander Robert returned 1,058,404 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-alexander-robert-returned-1058404-shares-to-the-6041860)
- 2025-05-15 14:25 UTC [SEC Form 25-NSE filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-allakos-inc-6041275)
- 2025-05-15 13:16 UTC [SEC Form 8-K] [Allakos Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allakos-inc-filed-sec-form-8-k-completion-of-acquisition-or-6041150)
- 2025-05-15 13:12 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-allakos-inc-6041133)
- 2025-05-12 14:24 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-allakos-inc-6032177)
- 2025-05-07 20:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-allakos-inc-6023735)
- 2025-04-17 20:01 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-allakos-inc-5992092)
- 2025-04-17 20:01 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-allakos-inc-5992082)
- 2025-04-15 20:01 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-allakos-inc-5988373)
- 2025-04-09 20:30 UTC [SEC Form SCHEDULE 13G filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-allakos-inc-5983009)
- 2025-04-03 20:40 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Allakos Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-allakos-inc-5976057)
- 2025-04-02 21:19 UTC [SEC Form SC14D9C filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-allakos-inc-5973380)
- 2025-04-02 12:15 UTC [SEC Form 8-K] [Allakos Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/allakos-inc-filed-sec-form-8-k-regulation-fd-disclosure-5971230)
- 2025-04-02 12:00 UTC [Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share](https://www.quantisnow.com/insight/allakos-inc-enters-into-agreement-to-be-acquired-by-concentra-5971126)
- 2025-03-13 20:22 UTC [SEC Form 8-K] [Allakos Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/allakos-inc-filed-sec-form-8-k-notice-of-delisting-or-5943359)
- 2025-03-12 20:11 UTC [SEC Form 10-K] [SEC Form 10-K filed by Allakos Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-allakos-inc-5940779)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ALLK
- Earnings history: https://www.quantisnow.com/earnings/ALLK
- Dividend history: https://www.quantisnow.com/dividends/ALLK
- Insider transactions: https://www.quantisnow.com/insiders/ALLK
- Options chain: https://www.quantisnow.com/options/ALLK
- SEC 8-K filings only: https://www.quantisnow.com/company/ALLK/8-k
- RSS and alerts for ALLK: https://www.quantisnow.com/docs/rss-feeds.md